Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | STAT1 | P42224 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2979039 | 1.00 | STAT3 (0.40) | STAT3STAT1 | |
| SCHEMBL27308 | 1.00 | STAT3 (0.40) | STAT3STAT1 | |
| SCHEMBL16286470 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL30713723 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL7650033 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL457013 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL9679890 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL5144296 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL30713725 | 0.98 | STAT3 (0.39) | STAT3STAT1 | |
| SCHEMBL27538404 | 0.98 | STAT3 (0.39) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661539-B1 | OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY | UNIV CALIFORNIA (US) | 2024-10-09 | — | — | EP | claimed |
| CN-110585165-B | Abuse resistant capsules | R·P·谢勒技术有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-109970708-B | Cannabinoid receptor modulators | 艾尼纳制药公司 | 2022-06-21 | — | — | CN | claimed |
| US-12629385-B2 | Stable AST-3424 injection preparation and preparation method | OBI PHARMA, INC. (TW) | 2026-05-19 | — | — | US | disclosed |
| EP-4710919-A1 | INJECTION PREPARATION AND PREPARATION METHOD THEREFOR, AND COMPATIBLE MEDICINAL LIQUID AND PREPARATION METHOD THEREFOR | Ascentawits Pharmaceuticals, Ltd. (CN) | 2026-03-18 | — | — | EP | disclosed |
| EP-4695258-A1 | BENZOPORPHYRIN ANALOGS, CONJUGATES, AND METHODS OF USE THEREOF | Nira Biosciences, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4695258-A1 | BENZOPORPHYRIN ANALOGS, CONJUGATES, AND METHODS OF USE THEREOF | Nira Biosciences, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260028349-A1 | DIMERIC FORM OF BENZOPORPHYRIN DERIVATIVE PHOTOSENSITIZER AND NANOPARTICLES AND METHODS THEREOF | UNIV MARYLAND (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4492044-A1 | SENSOR ELEMENT FOR OPTOCHEMICAL SENSORS | PyroScience GmbH (DE) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024216150-A1 | BENZOPORPHYRIN ANALOGS, CONJUGATES, AND METHODS OF USE THEREOF | NIRA BIOSCIENCES, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024216150-A1 | BENZOPORPHYRIN ANALOGS, CONJUGATES, AND METHODS OF USE THEREOF | NIRA BIOSCIENCES, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-114984229-A | Treatment of addiction and impulse control disorders using PDE7 inhibitors | 奥默罗斯公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-110585165-B | Abuse resistant capsules | R·P·谢勒技术有限公司 | 2022-08-12 | — | — | CN | disclosed |
| EP-4000601-A1 | STABLE AST-3424 INJECTION PREPARATION AND PREPARATION METHOD | Ascentawits Pharmaceuticals, Ltd. (CN) | 2022-05-25 | — | — | EP | disclosed |
| CN-114522152-A | Use of antistatic materials in airways for hot aerosol condensation processes | 艾利斯达医药品公司 | 2022-05-24 | — | — | CN | disclosed |
| CN-114522307-A | Use of antistatic materials in airways for hot aerosol condensation processes | 艾利斯达医药品公司 | 2022-05-24 | — | — | CN | disclosed |
| US-20220145172-A1 | POLYMERIC ORGANIC NANOPARTICLES WITH ENHANCED EMISSION | Sony Group Corporation (JP) | 2022-05-12 | — | — | US | disclosed |
| CN-111920959-B | ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof | 中国药科大学 | 2022-03-25 | — | — | CN | disclosed |
| CN-107750177-B | Use of antistatic materials in airways for hot aerosol condensation processes | 艾利斯达医药品公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-114173872-A | Methods and pharmaceutical compositions for treating drug overdose | 依那拉治疗股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028349-A1 | DIMERIC FORM OF BENZOPORPHYRIN DERIVATIVE PHOTOSENSITIZER AND NANOPARTICLES AND METHODS THEREOF | BRCA1, DDT, PPOX | STAT3 4233/4885STAT1 4548/4885 |
| US-12629385-B2 | Stable AST-3424 injection preparation and preparation method | SLC2A4, SLC2A8, F12 | STAT3 891/4885STAT1 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.